share_log

Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'

Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'

吉姆·克莱默权衡了帕洛阿尔托、礼来和Salesforce,称该股的目标股价上涨是一个 “危险信号”
Benzinga ·  02/28 03:59

During Tuesday's CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer emphasizing heightened threats following a recent breach at UnitedHealth.

在周二的CNBC投资俱乐部早间会议上,美国股市表现不一,这促使人们仔细研究当前的市场主题。网络安全已成为重点,吉姆·克莱默强调说,在UnitedHealth最近发生漏洞之后,威胁加剧。

What Happened: Cramer advocated for an aggressive long position in Palo Alto Networks Inc (NASDAQ:PANW) citing the growing demand for cybersecurity solutions amid escalating threats. The increasing prevalence of high-profile incidents underscores the significance of robust cybersecurity measures, reported CNBC.

发生了什么:克莱默主张在帕洛阿尔托网络公司(纳斯达克股票代码:PANW)持有激进的多头头寸,理由是在威胁不断升级的情况下,对网络安全解决方案的需求不断增长。据CNBC报道,备受瞩目的事件越来越普遍,凸显了强有力的网络安全措施的重要性。

Eli Lilly And Co (NYSE:LLY) faced stock declines as Viking Therapeutics Inc (NASDAQ:VKTX) presented promising results for its GLP-1 treatment, a potential rival. Cramer addressed concerns, highlighting the importance of substantial backing from pharmaceutical companies for market dominance. "Without the major backing of a pharmaceutical company, it's not enough [to beat out Eli Lilly,]" he said

礼来公司(纽约证券交易所代码:LLY)面临股价下跌,原因是维京疗法公司(纳斯达克股票代码:VKTX)公布了其潜在竞争对手 GLP-1 治疗的令人鼓舞的业绩。克莱默回应了担忧,强调了制药公司的大力支持对市场主导地位的重要性。他说:“没有制药公司的大力支持,[击败礼来] 是不够的。”

Wells Fargo raised its price target on Salesforce Inc (NYSE:CRM) shares to $300 from $290 ahead of quarterly results but maintained a hold rating, signaling potential challenges. Cramer interpreted this as a "red flag," cautioning investors about possible skepticism from analysts, which could impact sentiment post-earnings.

富国银行在季度业绩公布前将Salesforce Inc(纽约证券交易所代码:CRM)股票的目标股价从290美元上调至300美元,但维持持仓评级,这表明存在潜在挑战。克莱默将其解释为 “危险信号”,提醒投资者注意分析师可能持怀疑态度,这可能会影响财报后的情绪。

Why It Matters: In November 2023, Cramer predicted a "very good quarter" for cybersecurity firm Palo Alto Networks, indicating his long-standing faith in the sector, which further justifies his advice to go long on the company.

为何重要:2023年11月,克莱默预测网络安全公司帕洛阿尔托网络将出现 “非常不错的季度”,这表明了他对该行业的长期信心,这进一步证明了他对该公司的长期信心,这进一步证明了他对该公司的长期投资建议是合理的。

Earlier this month, Cramer warned of the potential impact of GLP-1s, a new class of weight loss and diabetes drugs, on food and beverage stocks, which might explain his reassurance about Eli Lilly's performance.

本月早些时候,克莱默警告说,一种新的减肥和糖尿病药物GLP-1对食品和饮料股的潜在影响,这也许可以解释他对礼来公司业绩的保证。

The price target increase by Wells Fargo comes amid a period of mixed views on Salesforce's performance. Earlier in the week, Citi analyst Tyler Radke raised the price target for Salesforce from $265 to $325, citing balanced investor sentiment and stabilizing demand signals.

富国银行上调目标股价之际,人们对Salesforce的表现持不同看法。本周早些时候,花旗分析师泰勒·拉德克将Salesforce的目标股价从265美元上调至325美元,理由是投资者情绪平衡,需求信号稳定。

Image Via Shutterstock

图片来自 Shutterstock

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发